In melanoma cell lines B16-F0 and B16-F1, approximately 30-40% of CSCs expressed CTLA-4, and blockade of CTLA-4 suppressed stem cell-like properties and significantly inhibited spheroid formation in vitro (85). Here, CTLA4 is linked to melanoma.